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Results: All four investigated splice variants of the primary transcript 
of Sur gene were expressed in NSCLC and lung tissues and their 
expression level decreased in the order Sur, Sur-ΔEx3, Sur-2B and Sur-
3B. The expression of all studied Sur transcript splice variants was sub-
stantially higher in NSCLC tissues as compared to matched lungs. In 
fact, in 71 (66%), 74 (69%), 79 (74%) and 56 (52%) of 107 examined 
NSCLC patients the tumors had more than tenfold higher mRNA level 
of Sur, Sur-ΔEx3, Sur-2B and Sur-3B, respectively, as compared to 
the lungs. Neither in the tumors nor in the lungs the different genotype 
(g/g, c/g or c/c) at the position -31 in the repressor element CDE2/CHR 
of Sur gene promoter had a signiﬁcant impact on the expression of the 
investigated Sur transcript splice variants. By contrast, the expression 
of all studied Sur transcript splice variants in the tumors, but not in the 
lungs, was signiﬁcantly higher in smokers than non-smokers. 
Conclusions: The present study provides evidence that transcripts en-
coding Sur, Sur-ΔEx3, Sur-2B and Sur-3B are overexpressed in the ma-
jority of NSCLC tissues, that the single nucleotide polymorphism at the 
position -31 in the Sur gene promoter does not signiﬁcantly inﬂuence 
the level of expression of the Sur transcript splice variants in NSCLC 
and lung tissues, and that smoking may further increase the upregulated 
expression of the Sur transcript splice variants in the tumors.
This work was supported by research projects NR/7860-5 and 
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Background: Induction of apoptosis in cancer cells is one of the tar-
gets for the development of potential chemotherapeutic agents. Betulin, 
a lupne-type triterpene, could be puriﬁed in some plant species and had 
been shown to exert cytotoxic effects in cancer cells. The antiprolifera-
tive effect of betulin on lung cancer cells was evaluated in this study. 
Methods: The cytotoxic and anti-proliferative of betulin to lung cancer 
cells were evaluated by the MTT assay and trypan blue exclusion assay 
at three repeated tests. The morphologic changes were monitored under 
the contrast-enhanced microscope. The apoptotic effects were evalu-
ated by Annexin-V and Hoechst 33342 staining. 
Results: On our preliminary data for screening the cytotoxicitic effect 
of several pure compounds puriﬁed from plants on lung cancer cells 
were evaluated. Betulin exhibited cytotoxicitic effect on A549 lung 
cancer cells. The IC50 values of betulin on A549 cancer cells ranged 
from 5 to 10 μg/ml after 48 h of treatment. After 72 h of exposure, 
betulin (10 μg/ml) could signiﬁcantly reduced A549 cell proliferation 
to 21 ± 2.8 % of control. Betulin could also induce apoptosis in A549 
cancer cells.
Conclusions: Betulin could induce apoptosis in human lung cancer 
cells. We would like to further elucidate the anti-proliferative mecha-
nisms in vitro and in vivo of betulin to the lung cancer cells. 
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Background: Recently we reported that aryl hydrocarbon receptor 
(AhR) over-expressed in the early stage of lung adenocarcinoma (AD). 
Furthermore, AhR overexpression promoted anchorage independent 
growth of lung AD cells. To identify novel proteins associated with 
AhR overexpression, we compared the protein proﬁles in parental and 
AhR interfered AD cells H1355 with the proteomic technique. 
Methods: AhR expression in AD cells H1355 was reduced with the 
small RNA technique. Several stable clones of AhR interfered cells 
were isolated. Differentially expressed proteins in parental cells and 
AhR interfered cells were identiﬁed with two-dimensional gel electro-
phoresis followed by LC/MS analysis, and then conﬁrmed by Western 
immunoblot. The relative mRNA levels were determined with the real-
time RT-PCR method.
Results: A total of 5 proteins were identiﬁed with the proteomic 
technique and conﬁrmed with the Western immunoblot. Among these 
proteins, the changes in heat shock protein 27 and galectin-1 were the 
most dramatic. The protein and mRNA levels of these two proteins 
were negatively correlated with AhR levels in AhR interfered cells and 
ﬁve lung cancer cell lines.
Conclusions: These results suggested that AhR level negatively regu-
late expression of heat shock protein 27 and galectin-1 in lung AD. The 
role and function of these two proteins in the development of lung AD 
deserve further investigation in the future.
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Background: To assay expression of CDA, RRM1, PTEN, ERCC1, 
dCK and RRM1(-)37A/C polymorphism which have been shown 
relevant to gemcitabine resistance in two human gemcitabine-resistant 
non-small cell lung cancer cell lines A549/Gem and H460/Gem so as to 
make clear how do they vary during the course of acquiring resistance 
to gemcitabine. 
Methods: Taking the human gemcitabine-resistant non-small cell 
lung cancer cell lines A549/Gem and H460/Gem which were estab-
lished by repeated clinical serous peak concentration then low but 
gradually increasing concentration of gemcitabine in our department 
as experimental objects, we used real-time ﬂuorescent quantitative 
RT-PCR to examine expression of CDA, RRM1, PTEN, ERCC1, dCK 
and RRM1(-)37A/C polymorphism at the different time point during 
introduction process. 
